Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by imaging - Dataset (ID:20219)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | 2nd Drug | Drug Concentration | Conc Unit | Time Point | Time Point Unit | Image | Measured Protein (Alexa Fluor 488) | Measured Protein Value (488) | Measured Protein (Alexa Fluor 568) | Measured Protein Value (568) | Measured Protein (Alexa Fluor 647) | Measured Protein Value (647) | Replicate | Plate Name | Plate Well |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.1280 | uM | 24 | hr | p27 Kip1 | 356.71 | p-Rb(S807/S811) | 166.33 | p-ERK(T202/Y204) | 71.63 | 1 | LOXIMVI-signal1 | F6 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0512 | uM | 24 | hr | p27 Kip1 | 338.89 | p-Rb(S807/S811) | 176.50 | p-ERK(T202/Y204) | 86.35 | 1 | LOXIMVI-signal1 | F7 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0205 | uM | 24 | hr | p27 Kip1 | 304.49 | p-Rb(S807/S811) | 193.11 | p-ERK(T202/Y204) | 131.86 | 1 | LOXIMVI-signal1 | F8 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0082 | uM | 24 | hr | p27 Kip1 | 310.13 | p-Rb(S807/S811) | 197.48 | p-ERK(T202/Y204) | 166.06 | 1 | LOXIMVI-signal1 | F9 | |
JNK-IN-8 | WM-115 | 2.0000 | uM | 24 | hr | p-Histone H3(S10) | 238.07 | p-Rb(S807/S811) | 80.65 | p-S6(S235/S236 | 200.44 | 1 | WM115-signal2 | D3 | ||
JNK-IN-8 | COLO 858 | 0.0205 | uM | 24 | hr | p27 Kip1 | 439.43 | p-Rb(S807/S811) | 169.34 | p-ERK(T202/Y204) | 657.25 | 1 | Colo858-signal1 | D8 | ||
JNK-IN-8 | WM-115 | 0.0512 | uM | 24 | hr | p-Histone H3(S10) | 224.01 | p-Rb(S807/S811) | 72.06 | p-S6(S235/S236 | 189.44 | 1 | WM115-signal2 | D7 | ||
JNK-IN-8 | WM-115 | 0.0082 | uM | 24 | hr | p-Histone H3(S10) | 222.98 | p-Rb(S807/S811) | 70.29 | p-S6(S235/S236 | 190.36 | 1 | WM115-signal2 | D9 | ||
Vemurafenib | WM-115 | JNK-IN-8 | 0.0033 | uM | 24 | hr | p-Histone H3(S10) | 205.62 | p-Rb(S807/S811) | 70.03 | p-S6(S235/S236 | 181.80 | 1 | WM115-signal2 | F10 | |
Vemurafenib | WM-115 | JNK-IN-8 | 2.0000 | uM | 24 | hr | p-Histone H3(S10) | 261.27 | p-Rb(S807/S811) | 47.45 | p-S6(S235/S236 | 41.16 | 1 | WM115-signal2 | F3 | |
Vemurafenib | WM-115 | JNK-IN-8 | 0.8000 | uM | 24 | hr | p-Histone H3(S10) | 201.42 | p-Rb(S807/S811) | 39.76 | p-S6(S235/S236 | 56.51 | 1 | WM115-signal2 | F4 | |
Vemurafenib | WM-115 | JNK-IN-8 | 0.1280 | uM | 24 | hr | p-Histone H3(S10) | 182.30 | p-Rb(S807/S811) | 53.72 | p-S6(S235/S236 | 104.93 | 1 | WM115-signal2 | F6 | |
Vemurafenib | WM-115 | JNK-IN-8 | 0.0512 | uM | 24 | hr | p-Histone H3(S10) | 199.08 | p-Rb(S807/S811) | 67.78 | p-S6(S235/S236 | 151.66 | 1 | WM115-signal2 | F7 | |
JNK-IN-8 | COLO 858 | 0.0082 | uM | 24 | hr | p27 Kip1 | 436.36 | p-Rb(S807/S811) | 155.67 | p-ERK(T202/Y204) | 648.15 | 1 | Colo858-signal1 | D9 | ||
Vemurafenib | LOXIMVI | 0.0033 | uM | 24 | hr | p-Histone H3(S10) | 290.41 | p-Rb(S807/S811) | 222.56 | p-S6(S235/S236 | 435.26 | 1 | LOXIMVI-signal2 | B10 | ||
Vemurafenib | LOXIMVI | 0.0000 | uM | 24 | hr | p-Histone H3(S10) | 304.49 | p-Rb(S807/S811) | 234.76 | p-S6(S235/S236 | 449.34 | 1 | LOXIMVI-signal2 | B11 | ||
Vemurafenib | LOXIMVI | 5.0000 | uM | 24 | hr | p-Histone H3(S10) | 210.99 | p-Rb(S807/S811) | 80.53 | p-S6(S235/S236 | 102.92 | 1 | LOXIMVI-signal2 | B2 | ||
Vemurafenib | LOXIMVI | 2.0000 | uM | 24 | hr | p-Histone H3(S10) | 203.52 | p-Rb(S807/S811) | 97.55 | p-S6(S235/S236 | 181.29 | 1 | LOXIMVI-signal2 | B3 | ||
Vemurafenib | LOXIMVI | 0.8000 | uM | 24 | hr | p-Histone H3(S10) | 237.39 | p-Rb(S807/S811) | 127.65 | p-S6(S235/S236 | 339.13 | 1 | LOXIMVI-signal2 | B4 | ||
Vemurafenib | LOXIMVI | 0.3200 | uM | 24 | hr | p-Histone H3(S10) | 239.52 | p-Rb(S807/S811) | 154.83 | p-S6(S235/S236 | 375.76 | 1 | LOXIMVI-signal2 | B5 | ||
Vemurafenib | LOXIMVI | 0.1280 | uM | 24 | hr | p-Histone H3(S10) | 282.64 | p-Rb(S807/S811) | 182.20 | p-S6(S235/S236 | 400.81 | 1 | LOXIMVI-signal2 | B6 | ||
Vemurafenib | LOXIMVI | 0.0512 | uM | 24 | hr | p-Histone H3(S10) | 255.47 | p-Rb(S807/S811) | 192.91 | p-S6(S235/S236 | 440.25 | 1 | LOXIMVI-signal2 | B7 | ||
Vemurafenib | LOXIMVI | 0.0205 | uM | 24 | hr | p-Histone H3(S10) | 298.38 | p-Rb(S807/S811) | 219.79 | p-S6(S235/S236 | 438.42 | 1 | LOXIMVI-signal2 | B8 | ||
Vemurafenib | LOXIMVI | 0.0082 | uM | 24 | hr | p-Histone H3(S10) | 288.44 | p-Rb(S807/S811) | 221.82 | p-S6(S235/S236 | 462.92 | 1 | LOXIMVI-signal2 | B9 | ||
Vemurafenib | WM-115 | 0.0082 | uM | 24 | hr | Ki-67 | 788.63 | p-Rb(S807/S811) | 73.58 | p-cJun(S73) | 49.70 | 1 | WM115-signal3 | B9 |